- Home
- RCAT vs PVLA Comparison
RCAT vs PVLA Comparison
Compare RCAT & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCAT | PVLA |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCAT | PVLA |
|---|---|---|
| Price | $11.14 | $127.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | $20.00 | ★ $171.87 |
| AVG Volume (30 Days) | ★ 9.2M | 165.9K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,836,382.00 | N/A |
| Revenue This Year | $271.60 | N/A |
| Revenue Next Year | $41.21 | $104,350.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 79.95 | N/A |
| 52 Week Low | $5.12 | $20.20 |
| 52 Week High | $18.78 | $151.18 |
Technical Indicators
Market Signals| Indicator | RCAT | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 53.25 |
| Support Level | $11.01 | $108.99 |
| Resistance Level | $13.69 | $135.23 |
| Average True Range (ATR) | 0.86 | 6.87 |
| MACD | -0.11 | -0.53 |
| Stochastic Oscillator | 15.69 | 48.47 |
Price Performance
Historical ComparisonAbout RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.